Exendin-4 (Ex-4), a lizard salivary gland peptide, that has high sequence homology to mammalian GLP-1 and is resistant to enzymatic degradation [8] has been approved for the treatment of type-2 diabetes since 2005 [11]. This evidence concerns the gene GLP1R and type 2 diabetes mellitus.